Health status of Asian Americans

New "AI Doctor" Predicts Hospital Readmission and Other Health Outcomes

Retrieved on: 
Wednesday, June 7, 2023
Infection, Insurance, Human, Nature, Data science, Workflow, LLM, Sofinnova, Mirati Therapeutics, Health status of Asian Americans, NYU, Radiology, New York University Grossman School of Medicine, Woman, Nvidia, MBA, Research, Doctor of Philosophy, National Institutes of Health, Computer, Bachelor of Science, Language, Abbreviation, Judgement, Bangladesh Technical Education Board, NYU Langone Health, Hospital, Patient, Physician, Risk, New York University Center for Data Science, Artificial intelligence, AI, Health, Death, Health information management, Software, Medical device, Nursing, Pharmaceutical industry, MD, Neurosurgery

NEW YORK, June 7, 2023 /PRNewswire/ -- An artificial intelligence (AI) computer program can read physicians' notes to accurately estimate patients' risk of death, length of hospital stay, and other factors important to care. Designed by a team led by researchers at NYU Grossman School of Medicine, the tool is currently in use in its affiliated hospitals to predict the chances that a patient who is discharged will be readmitted within a month.

Key Points: 
  • Experts have long explored computer algorithms meant to improve healthcare, with some having been shown to make valuable clinical predictions.
  • "Since NYUTron reads information taken directly from the electronic health record, its predictive models can be easily built and quickly implemented through the healthcare system."
  • The terms and conditions of these arrangements are being managed in accordance with the policies and practices of NYU Langone Health.
  • Other study authors included Nima Pour Nejatian, PhD, MBA, at nVidia in Santa Clara, Calif., whose computer hardware was used to build NYUTron.

Global Motorcycle Infotainment System Market Report 2023: Players Include Harley-Davidson, Honda Motor, Polaris Industries and Sena Technologies - ResearchAndMarkets.com

Retrieved on: 
Friday, June 2, 2023
Other Entertainment, Motorcycles, Entertainment, Automotive, Motorcycle, Original equipment manufacturer, Tablet, Health status of Asian Americans, Communication, Growth, BMW, Car, Multimedia, Investment, Honda, Harley-Davidson, Internet, Software, Transport, Mobile phone, Yamaha

Motorcycle infotainment system provides both the entertainment and information to rider while riding a motorcycle.

Key Points: 
  • Motorcycle infotainment system provides both the entertainment and information to rider while riding a motorcycle.
  • Motorcycle infotainment system is an integration of multimedia and driver assisting technologies in a single module.
  • Thus, increased dependency on technology coupled with rising need for continuous connectivity is driving the growth prospects of the motorcycle infotainment system market worldwide.
  • On the other hand, distraction caused due to the infotainment systems can be a serious safety concern, which may acts as a challenge for the growth of the motorcycle infotainment system market.

Commercial Health Plan Member Satisfaction Declines in Key Areas, J.D. Power Finds

Retrieved on: 
Wednesday, May 31, 2023
Professional Services, Health, Other Consumer, Consumer, Data Analytics, Insurance, Other Health, Health status of Asian Americans, J.D. Power, NPS, Communication, Digital, Commercial, Prescription, Sicker, SM, Patient, Conditional sentence, Generation Z, Nursing, Health insurance

Power 2023 U.S. Commercial Member Health Plan Study,SM released today, customer satisfaction with commercial health plans is particularly strained among members of Gen Y1 and Gen Z, driven largely by poor customer service and communication scores.

Key Points: 
  • Power 2023 U.S. Commercial Member Health Plan Study,SM released today, customer satisfaction with commercial health plans is particularly strained among members of Gen Y1 and Gen Z, driven largely by poor customer service and communication scores.
  • Similarly, members with the lowest self-reported health status are most likely to experience communications challenges with their health plans.
  • Despite investment in digital health tools, health plan member usage remains low: Digital usage for all tools and support remains below 50%.
  • The study is based on responses from 32,656 commercial health plan members and was fielded from January through April 2023.

Tevogen Bio will Present Positive Proof-of-Concept Trial Findings at the 5th Annual Allogeneic Cell Therapies Summit in Boston, MA

Retrieved on: 
Monday, May 22, 2023
Science, Biotechnology, Research, Health, COVID-19, Infectious Diseases, Genetics, Clinical Trials, Infection, Weapon, Antigen, Cytokine release syndrome, Omicron, Bio, SARS-CoV-2, Principal investigator, Health status of Asian Americans, Clinical trial, Cancer, Viral, Multimedia, DNP, TVGN, Incidence, Genome, MD, Patient, Thomas Jefferson University Hospital, Viral load, Cytotoxic T cell, Clinical, PCR, Safety, Pharmaceutical industry, Vaccine, Long COVID

Tevogen Bio is pleased to announce that it will present the proof-of-concept clinical trial results of TVGN 489, the company's first clinical product from its ExacTcell platform , at the 5th Annual Allogeneic Therapies Summit in Boston, MA.

Key Points: 
  • Tevogen Bio is pleased to announce that it will present the proof-of-concept clinical trial results of TVGN 489, the company's first clinical product from its ExacTcell platform , at the 5th Annual Allogeneic Therapies Summit in Boston, MA.
  • CD8+ CTLs in ExacTcell based products target multiple and distinct antigens to overcome potential mutational challenges, such as TVGN 489.
  • “We believe that cell therapies are expected to be the norm, not the exception,” said Tevogen CEO Ryan Saadi, M.D., M.P.H.
  • “Tevogen aspires and is designed to be the very first biotech to achieve commercial success and patient affordability through advanced science and efficient business models.”

Lifespin Announces the Launch of its First Commercial Product in Regulated Healthcare

Retrieved on: 
Monday, May 22, 2023
Software as a service, Obesity, Therapeutic drug monitoring, Diabetes, Health status of Asian Americans, Dicarboxylic acid, Science, Metabolism, Patient, Physician, Algorithm, Amino acid, Health, Medical device

REGENSBURG, Germany, May 22, 2023 /PRNewswire/ -- Lifespin GmbH, a start-up medical diagnostics company with offices in Regensburg (Germany) and Boston (MA), announced today that it has launched Lifespin™ Amino Acid Profiler (LAAP) - its first commercial product for use in the regulated diagnostics field. Utilizing its proprietary AI-driven technology, Lifespin LAAP analyzes variations in patients' metabolism to provide clinicians with deep insights into patients' health and wellbeing.

Key Points: 
  • REGENSBURG, Germany, May 22, 2023 /PRNewswire/ -- Lifespin GmbH, a start-up medical diagnostics company with offices in Regensburg (Germany) and Boston (MA), announced today that it has launched Lifespin™ Amino Acid Profiler (LAAP) - its first commercial product for use in the regulated diagnostics field.
  • Utilizing its proprietary AI-driven technology, Lifespin LAAP analyzes variations in patients' metabolism to provide clinicians with deep insights into patients' health and wellbeing.
  • Amino acids have been shown to play a fundamental role in maintaining and controlling the normal physiological processes of the human body.
  • Analysis of the samples will be implemented by Lifespin at its sites in Germany and the US, utilizing its advanced and proprietary testing algorithms, and delivered to laboratory chain companies and healthcare providers as a Software-as-a-Service (SaaS).

Cytokinetics Presents New Data in Patients With Non-Obstructive HCM From Cohort 4 of REDWOOD-HCM in Late-Breaking Clinical Trial Session at The European Society of Cardiology Heart Failure 2023 Congress

Retrieved on: 
Saturday, May 20, 2023
Well, CSS, Functional, Heart, NYHA, Research and development, Clinical study design, Week, Cohort, LVEF, Health status of Asian Americans, Angina, Hypertrophy, Oregon Health and Science University Center for Women's Health, Dizziness, Cytokinetics, Patient, N-terminal prohormone of brain natriuretic peptide, Cardiology, Heart failure, SE, European Society for Primary Immunodeficiencies, International Congress on Tuberculosis, Pharmaceutical industry, KCCQ, HCM

SOUTH SAN FRANCISCO, May 20, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional data from Cohort 4 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), a Phase 2, open-label clinical trial of aficamten in patients with non-obstructive hypertrophic cardiomyopathy (nHCM), were presented in a Late Breaking Clinical Trial session at Heart Failure 2023 an International Congress of the European Society of Cardiology taking place online and in Prague, Czech Republic from May 20, 2023 – May 23, 2023.

Key Points: 
  • We look forward to advancing aficamten into a Phase 3 clinical trial in patients with nHCM which is expected to begin in the second half of this year.”
    The new data from Cohort 4, presented today by Ahmad Masri, M.D.
  • At 10 weeks, treatment with aficamten was associated with an average improvement in KCCQ-CSS of 10.6 points (p
  • Additionally, 56% of patients demonstrated improvement of ≥1 New York Heart Association (NYHA) Functional Class (p = 0.011) (Figure 2).
  • Four patients (9.8%) had serious adverse events, including one previously reported death, and none were attributed to aficamten.

Tampa General Hospital Teams Up with Navina to Bring Its Transformative AI to Primary Care Physicians

Retrieved on: 
Thursday, May 18, 2023
Intelligence cycle, Partnership, Health status of Asian Americans, Tampa General Hospital, Hospital, Patient, Physician, TGH, Artificial intelligence, City, AI, Health, Medical device, Pharmaceutical industry, Nursing, Innovation, Navina Bole

NEW YORK and TAMPA, Fla., May 18, 2023 /PRNewswire/ -- Navina, the Artificial Intelligence (AI)-powered platform that transforms large amounts of patient data into actionable primary care, and Tampa General Hospital (TGH), a 1,040-bed, not-for-profit, academic medical center and one of the largest hospitals in the United States, have announced a new partnership to bring Navina's AI to the health system's primary care clinicians.

Key Points: 
  • Clinicians using Navina's platform can quickly assess diagnoses and opportunities to improve care and compliance with quality measures.
  • Tampa General's partnership with Navina will bring innovative technology to primary care physicians to better serve their growing patient populations.
  • "At Navina, we are passionate about improving the lives of physicians and patients, and to accomplish that we need extraordinarily committed partners like Tampa General," said Ronen Lavi, Navina CEO and co-founder.
  • We are privileged to be working with Tampa General to empower doctors to spend less time digesting data and more time interacting with the patients they care for."

Global Home Health Hub Market to Garner High Returns by 2029 - Brandessence Market Research

Retrieved on: 
Monday, May 15, 2023
Performing Life, Inc, Prevalence, Diabetes, Internet, Health status of Asian Americans, COVID-19, Ageing, Quality of life, Geisinger Health System, Privacy, USD, Hypertension, Remote patient monitoring, Cisco, Siemens Healthineers, Honeywell, Hospital, Acquisition, Biotelemetry, Qualcomm, Patient, Others, Risk, Chronic condition, IDEAL, Conditional sentence, Growth, Philips, RPM, Caregiver, Pharmaceutical industry, Dentistry, Mobile phone, Nursing, Medical device, Health insurance, Network equipment provider

Home health hubs, also known as home health gateways, are innovative technology platforms that connect patients, caregivers, and healthcare providers in real-time.

Key Points: 
  • Home health hubs, also known as home health gateways, are innovative technology platforms that connect patients, caregivers, and healthcare providers in real-time.
  • Global Home Health Hub Market is slated to register a CAGR of 38.3% over 2022-2029.
  • Bargaining power of buyers: The bargaining power of buyers in the home health hub market is high.
  • Competitive rivalry: The competitive rivalry in the home health hub market is high.

Global Home Health Hub Market to Garner High Returns by 2029 - Brandessence Market Research

Retrieved on: 
Monday, May 15, 2023
Performing Life, Inc, Prevalence, Diabetes, Internet, Health status of Asian Americans, COVID-19, Ageing, Quality of life, Geisinger Health System, Privacy, USD, Hypertension, Remote patient monitoring, Cisco, Siemens Healthineers, Honeywell, Hospital, Acquisition, Biotelemetry, Qualcomm, Patient, Others, Risk, Chronic condition, IDEAL, Conditional sentence, Growth, Philips, RPM, Caregiver, Pharmaceutical industry, Dentistry, Mobile phone, Nursing, Medical device, Health insurance, Network equipment provider

Home health hubs, also known as home health gateways, are innovative technology platforms that connect patients, caregivers, and healthcare providers in real-time.

Key Points: 
  • Home health hubs, also known as home health gateways, are innovative technology platforms that connect patients, caregivers, and healthcare providers in real-time.
  • Global Home Health Hub Market is slated to register a CAGR of 38.3% over 2022-2029.
  • Bargaining power of buyers: The bargaining power of buyers in the home health hub market is high.
  • Competitive rivalry: The competitive rivalry in the home health hub market is high.

Precision Swine Farming Market worth $711 million by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, May 9, 2023
Fruit, Farmer, Food safety, Livestock, Pain, Risk, Region, Demand generation, Component, Monitoring, Control system, Health status of Asian Americans, Injury, Ageing, Needle, USD, Hardware, Growth, Behavior, Safety, AGCO, Flower, Disease, Bio, Business, CTB, Record, Uniloc USA, Inc. v. Microsoft Corp., Journal of Agricultural, Biological and Environmental Statistics, Automation, Weight gain, Animal, Pheromone, Merck & Co., Hydroponics, Infection, Data management, Aquaculture, Marketing, Movement, Aquaponics, Peripheral, Site, Health, Biofertilizer, Pig, Agriculture, Agroecology, Software, Silvopasture, Vegetable

The precision swine farming market is experiencing an increasing demand for needle-free injection systems.

Key Points: 
  • The precision swine farming market is experiencing an increasing demand for needle-free injection systems.
  • Swine identification and tracking systems are increasingly in demand in the precision swine farming market.
  • Furthermore, the increasing demand for efficiency and production has further contributed to Europe's dominance in the precision swine farming market.
  • The study includes an in-depth competitive analysis of these key players in the precision swine farming market with their company profiles, recent developments, and key market strategies.